Based on comprehensive analysis of clinical samples from MASLD patients and experimental mouse models, we demonstrate that elevated hepatic and plasma proline levels, resulting from increased P5CS expression, are strongly correlated with disease severity. This evidence concerns the gene ALDH18A1 and metabolic dysfunction-associated steatotic liver disease.